BioIntelligence Technologies, based in Sherbrooke, QC, Canada, develops AI-powered instruments and software to monitor, understand, predict, and optimize industrial bioprocesses using fermentation. Its core product, the BioIntelligence Analytics Solution™ (BAS™), measures microorganism evolution, nutrient consumption, and product synthesis directly in fermenters and bioreactors and performs advanced customized analytics in real time for plant operators. BAS™ is already commercial with industrial clients in North America and Europe. The company says its solutions reduce product losses, cut water and energy consumption, and lower CO2 emissions while improving consistency and profitability for industrial clients. Led by CEO and founder Joel Sirois, BioIntelligence creates and commercializes intelligent instruments and software for biotech companies. It raised $5M to accelerate growth in America and Europe. Founded in 2014 and based in Sherbrooke, BioIntelligence Technologies has developed two proprietary technology platforms and licensed a third from the University of Sherbrooke to optimize biological processes in real time. Its smart probes and server-analysts (the BioAnalyst product) monitor multiple key variables and recommend actions to maximize the profitability of biological cultures. The company completed a first financing round to support commercialization of the BioAnalyst and to accelerate development of additional products. Management says initial commercial targets are industrial biotechnology customers in the U.S. and Europe, with biopharmaceuticals targeted later at a global scale. BioIntelligence operates from the Espace-INC incubator and has received local acceleration support from Sherbrooke Innopole and ACET. The company has also won regional entrepreneurial awards and competitions in 2015.

Total raised

$6M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2024